The authors summarize how genetically-engineered mouse models of SCLC have contributed significantly to our understanding of the disease in the past two decades, as well as recent advances in modeling SCLC in mice that allow investigators to bypass limitations of the previous generation of genetically-engineered mouse models.
[Oncogene]
